GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic AS (CHIX:BAVAc) » Definitions » Cyclically Adjusted Price-to-FCF

Bavarian Nordic AS (CHIX:BAVAC) Cyclically Adjusted Price-to-FCF : (As of Jun. 06, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Bavarian Nordic AS Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Bavarian Nordic AS Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Bavarian Nordic AS's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic AS Cyclically Adjusted Price-to-FCF Chart

Bavarian Nordic AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Bavarian Nordic AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Bavarian Nordic AS's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Bavarian Nordic AS's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bavarian Nordic AS's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bavarian Nordic AS's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Bavarian Nordic AS's Cyclically Adjusted Price-to-FCF falls into.


;
;

Bavarian Nordic AS Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Bavarian Nordic AS's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Bavarian Nordic AS's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-9.315/120.2000*120.2000
=-9.315

Current CPI (Mar. 2025) = 120.2000.

Bavarian Nordic AS Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -8.639 100.300 -10.353
201509 -1.291 100.200 -1.549
201512 -4.700 99.800 -5.661
201603 -2.448 100.200 -2.937
201606 -2.881 100.600 -3.442
201609 -6.366 100.200 -7.637
201612 15.262 100.300 18.290
201703 4.158 101.200 4.939
201706 7.430 101.200 8.825
201709 -2.173 101.800 -2.566
201712 -5.521 101.300 -6.551
201803 -5.829 101.700 -6.889
201806 -3.884 102.300 -4.564
201809 -0.721 102.400 -0.846
201812 -1.876 102.100 -2.209
201903 -4.469 102.900 -5.220
201906 -8.743 102.900 -10.213
201909 -4.559 102.900 -5.325
201912 -58.216 102.900 -68.004
202003 9.225 103.300 10.734
202006 3.505 103.200 4.082
202009 4.020 103.500 4.669
202012 -15.424 103.400 -17.930
202103 -3.619 104.300 -4.171
202106 -5.991 105.000 -6.858
202109 -0.798 105.800 -0.907
202112 -11.968 106.600 -13.495
202203 -3.992 109.900 -4.366
202206 -3.449 113.600 -3.649
202209 -0.875 116.400 -0.904
202212 -8.226 115.900 -8.531
202303 -6.200 117.300 -6.353
202306 1.652 116.400 1.706
202309 1.716 117.400 1.757
202312 4.414 116.700 4.546
202403 5.617 118.400 5.702
202406 -0.258 118.500 -0.262
202409 -6.007 118.900 -6.073
202412 4.070 118.900 4.114
202503 -9.315 120.200 -9.315

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bavarian Nordic AS  (CHIX:BAVAc) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Bavarian Nordic AS Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic AS's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Bavarian Nordic AS Business Description

Industry
Address
Philip Heymans Alle 3, Hellerup, DNK, 2900
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.

Bavarian Nordic AS Headlines

No Headlines